144 related articles for article (PubMed ID: 16736039)
1. Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia.
Pattinson KT; Rogers R; Mayhew SD; Tracey I; Wise RG
J Cereb Blood Flow Metab; 2007 Feb; 27(2):414-23. PubMed ID: 16736039
[TBL] [Abstract][Full Text] [Related]
2. Opioids depress cortical centers responsible for the volitional control of respiration.
Pattinson KT; Governo RJ; MacIntosh BJ; Russell EC; Corfield DR; Tracey I; Wise RG
J Neurosci; 2009 Jun; 29(25):8177-86. PubMed ID: 19553457
[TBL] [Abstract][Full Text] [Related]
3. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil.
Wise RG; Rogers R; Painter D; Bantick S; Ploghaus A; Williams P; Rapeport G; Tracey I
Neuroimage; 2002 Aug; 16(4):999-1014. PubMed ID: 12202088
[TBL] [Abstract][Full Text] [Related]
4. The voxel-wise analysis of false negative fMRI activation in regions of provoked impaired cerebrovascular reactivity.
van Niftrik CHB; Piccirelli M; Muscas G; Sebök M; Fisher JA; Bozinov O; Stippich C; Valavanis A; Regli L; Fierstra J
PLoS One; 2019; 14(5):e0215294. PubMed ID: 31059517
[TBL] [Abstract][Full Text] [Related]
5. Altered Signaling in the Descending Pain-modulatory System after Short-Term Infusion of the μ-Opioid Agonist Remifentanil.
Sprenger C; Eichler IC; Eichler L; Zöllner C; Büchel C
J Neurosci; 2018 Mar; 38(10):2454-2470. PubMed ID: 29440535
[TBL] [Abstract][Full Text] [Related]
6. Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences.
Cohen ER; Rostrup E; Sidaros K; Lund TE; Paulson OB; Ugurbil K; Kim SG
Neuroimage; 2004 Oct; 23(2):613-24. PubMed ID: 15488411
[TBL] [Abstract][Full Text] [Related]
7. Imaging the Respiratory Effects of Opioids in the Human Brain.
Pattinson KT; Wise RG
Adv Exp Med Biol; 2016; 903():145-56. PubMed ID: 27343094
[TBL] [Abstract][Full Text] [Related]
8. Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil.
Wagner KJ; Sprenger T; Kochs EF; Tölle TR; Valet M; Willoch F
Anesthesiology; 2007 Mar; 106(3):548-56. PubMed ID: 17325514
[TBL] [Abstract][Full Text] [Related]
9. Impact of abnormal cerebrovascular reactivity on BOLD fMRI: a preliminary investigation of moyamoya disease.
Mazerolle EL; Ma Y; Sinclair D; Pike GB
Clin Physiol Funct Imaging; 2018 Jan; 38(1):87-92. PubMed ID: 27572110
[TBL] [Abstract][Full Text] [Related]
10. Detection and scaling of task-induced fMRI-BOLD response using resting state fluctuations.
Kannurpatti SS; Biswal BB
Neuroimage; 2008 May; 40(4):1567-74. PubMed ID: 18343159
[TBL] [Abstract][Full Text] [Related]
11. Opioid suppression of conditioned anticipatory brain responses to breathlessness.
Hayen A; Wanigasekera V; Faull OK; Campbell SF; Garry PS; Raby SJM; Robertson J; Webster R; Wise RG; Herigstad M; Pattinson KTS
Neuroimage; 2017 Apr; 150():383-394. PubMed ID: 28062251
[TBL] [Abstract][Full Text] [Related]
12. Low-dose remifentanil increases regional cerebral blood flow and regional cerebral blood volume, but decreases regional mean transit time and regional cerebrovascular resistance in volunteers.
Lorenz IH; Kolbitsch C; Schocke M; Kremser C; Zschiegner F; Hinteregger M; Felber S; Hörmann C; Benzer A
Br J Anaesth; 2000 Aug; 85(2):199-204. PubMed ID: 10992824
[TBL] [Abstract][Full Text] [Related]
13. Vascular component analysis of hyperoxic and hypercapnic BOLD contrast.
Schwarzbauer C; Deichmann R
Neuroimage; 2012 Feb; 59(3):2401-12. PubMed ID: 21945792
[TBL] [Abstract][Full Text] [Related]
14. Vascular autorescaling of fMRI (VasA fMRI) improves sensitivity of population studies: A pilot study.
Kazan SM; Mohammadi S; Callaghan MF; Flandin G; Huber L; Leech R; Kennerley A; Windischberger C; Weiskopf N
Neuroimage; 2016 Jan; 124(Pt A):794-805. PubMed ID: 26416648
[TBL] [Abstract][Full Text] [Related]
15. Carotid endarterectomy improves cerebrovascular reserve capacity preferentially in patients with preoperative impairment as indicated by asymmetric BOLD response to hypercapnia.
Goode SD; Altaf N; Auer DP; MacSweeney ST
Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):546-51. PubMed ID: 19744868
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in the coupling of cerebral blood flow and oxygen metabolism changes in response to activation: implications for BOLD-fMRI.
Ances BM; Leontiev O; Perthen JE; Liang C; Lansing AE; Buxton RB
Neuroimage; 2008 Feb; 39(4):1510-21. PubMed ID: 18164629
[TBL] [Abstract][Full Text] [Related]
17. Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index.
Nieuwenhuijs DJ; Olofsen E; Romberg RR; Sarton E; Ward D; Engbers F; Vuyk J; Mooren R; Teppema LJ; Dahan A
Anesthesiology; 2003 Feb; 98(2):312-22. PubMed ID: 12552187
[TBL] [Abstract][Full Text] [Related]
18. Invalidation of fMRI experiments secondary to neurovascular uncoupling in patients with cerebrovascular disease.
Para AE; Sam K; Poublanc J; Fisher JA; Crawley AP; Mikulis DJ
J Magn Reson Imaging; 2017 Nov; 46(5):1448-1455. PubMed ID: 28152241
[TBL] [Abstract][Full Text] [Related]
19. Remifentanil and the brain.
Fodale V; Schifilliti D; Praticò C; Santamaria LB
Acta Anaesthesiol Scand; 2008 Mar; 52(3):319-26. PubMed ID: 18269383
[TBL] [Abstract][Full Text] [Related]
20. Functional MRI-based identification of brain regions activated by mechanical noxious stimulation and modulatory effect of remifentanil in cats.
Nagakubo D; Hamamoto Y; Hasegawa D; Kamata M; Iizuka T; Muta K; Fujita N; Nakagawa T; Nishimura R
Res Vet Sci; 2017 Oct; 114():444-449. PubMed ID: 28772233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
